0

Journal Articles

in Diabetic Retinopathy
 1-20 of 112 Articles
JAMA Ophthalmology | 
Small Case Series |  May 02, 2013 ONLINE FIRST
Intravitreal Fasudil Combined With Bevacizumab for Persistent Diabetic Macular Edema: A Novel Treatment
Hamid Ahmadieh, MD; Ramin Nourinia, MD; Ali Hafezi-Moghadam, MD, PhD
JAMA Ophthalmol. 2013;():1-2. doi:10.1001/jamaophthalmol.2013.143.
JAMA Ophthalmology | 
Clinical Sciences |  April 18, 2013 ONLINE FIRST
Macular Edema After Cataract Surgery in Eyes Without Preoperative Central-Involved Diabetic Macular Edema
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol. 2013;():1-9. doi:10.1001/jamaophthalmol.2013.2313.
INCLUDES: , Supplemental Content
JAMA Ophthalmology | 
Clinical Trials |  March 01, 2013
Randomized Clinical Trial Evaluating Intravitreal Ranibizumab or Saline for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol. 2013;131(3):283-293. doi:10.1001/jamaophthalmol.2013.2015.
INCLUDES: , Supplemental Content
JAMA Ophthalmology | 
Clinical Sciences |  March 01, 2013
Automated Analysis of Retinal Images for Detection of Referable Diabetic Retinopathy
Michael D. Abràmoff, MD, PhD; James C. Folk, MD; Dennis P. Han, MD; et al.
JAMA Ophthalmol. 2013;131(3):351-357. doi:10.1001/jamaophthalmol.2013.1743.
JAMA | 
Editorial |  December 12, 2012
Diabetes and Nonrefractive Visual Impairment:  The Young Have It
David C. Musch, PhD, MPH; Thomas W. Gardner, MD, MS
JAMA. 2012;308(22):2403-2404. doi:10.1001/jama.2012.114286.
JAMA | 
Original Contribution |  December 12, 2012
Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008
Fang Ko, MD; Susan Vitale, PhD, MHS; Chiu-Fang Chou, DrPH; et al.
JAMA. 2012;308(22):2361-2368. doi:10.1001/jama.2012.85685.
INCLUDES: CME , Supplemental Content
JAMA Internal Medicine | 
Invited Commentary |  November 26, 2012
The Promise of Primary Care–Based Screening for Diabetic Retinopathy:  The Devil Will Be in the Details
Comment on “Telemedicine and Retinal Imaging for Improving Diabetic Retinopathy Evaluation”
Lauren Patty Daskivich, MD, MSHS; Carol M. Mangione, MD, MSPH
Arch Intern Med. 2012;172(21):1678-1680. doi:10.1001/2013.jamainternmed.406.
JAMA Internal Medicine | 
Research Letters |  November 26, 2012
Telemedicine and Retinal Imaging for Improving Diabetic Retinopathy Evaluation
Seema Garg, MD, PhD; Pooja D. Jani, MD; Abhijit V. Kshirsagar, MD, MPH; et al.
Arch Intern Med. 2012;172(21):1677-1680. doi:10.1001/archinternmed.2012.4372.
JAMA Ophthalmology | 
Clinical Sciences |  September 01, 2012
Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression
Michael S. Ip, MD; Amitha Domalpally, MD; J. Jill Hopkins, MD; et al.
Arch Ophthalmol. 2012;130(9):1145-1152. doi:10.1001/archophthalmol.2012.1043.
INCLUDES: , Supplemental Content
JAMA Ophthalmology | 
Clinical Sciences |  September 01, 2012
Factors Associated With Changes in Visual Acuity and Central Subfield Thickness at 1 Year After Treatment for Diabetic Macular Edema With Ranibizumab
Susan B. Bressler, MD; Haijing Qin, MS; Roy W. Beck, MD, PhD; et al.
Arch Ophthalmol. 2012;130(9):1153-1161. doi:10.1001/archophthalmol.2012.1107.
INCLUDES: , Supplemental Content
JAMA Ophthalmology | 
Clinical Sciences |  September 01, 2012
Angiofibrotic Response to Vascular Endothelial Growth Factor Inhibition in Diabetic Retinal Detachment:  Report No. 1
Elliott H. Sohn, MD; Shikun He, MD; Leo A. Kim, MD, PhD; et al.
Arch Ophthalmol. 2012;130(9):1127-1134. doi:10.1001/archophthalmol.2012.1611.
INCLUDES: , Supplemental Content
JAMA Ophthalmology | 
Clinical Sciences |  September 01, 2012
Retinopathy and Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort (CRIC) Study
Juan E. Grunwald, MD; Judith Alexander, BA; Gui-Shuang Ying, PhD; et al.
Arch Ophthalmol. 2012;130(9):1136-1144. doi:10.1001/archophthalmol.2012.1800.
INCLUDES: CME
JAMA Ophthalmology | 
Clinical Trials |  August 01, 2012
A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema:  24-Month Data: Report 3
Ranjan Rajendram, MD, FRCOphth; Samantha Fraser-Bell, PhD, FRANZCO; Andrew Kaines, FRANZCO; et al.
Arch Ophthalmol. 2012;130(8):972-979. doi:10.1001/archophthalmol.2012.393.
JAMA Internal Medicine | 
Original Investigation |  July 09, 2012
Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes
Iskandar Idris, MD, FRCP, FRCP(Edin); Graham Warren, PhD; Richard Donnelly, MD, PhD
Arch Intern Med. 2012;172(13):1005-1011. doi:10.1001/archinternmed.2012.1938.
JAMA Internal Medicine | 
Evidence to Practice |  July 09, 2012
Comparative Effectiveness of Anti–Growth Factor Therapies for Diabetic Macular Edema:  Summary of Primary Findings and Conclusions
Patrick G. O’Malley, MD, MPH
Arch Intern Med. 2012;172(13):1014-1015. doi:10.1001/archinternmed.2012.2335.
JAMA Internal Medicine | 
Invited Commentary |  July 09, 2012
Thiazolidinediones and Macular Edema:  Comment on “Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes”
Sonal Singh, MD, MPH; Jodi B. Segal, MD, MPH
Arch Intern Med. 2012;172(13):1011-1013. doi:10.1001/archinternmed.2012.2461.
JAMA Ophthalmology | 
Epidemiology |  June 01, 2012
Vitamin D and Retinopathy in Adults With Diabetes Mellitus
Patricia A. Patrick, DrPH; Paul F. Visintainer, PhD; Qiuhu Shi, PhD; et al.
Arch Ophthalmol. 2012;130(6):756-760. doi:10.1001/archophthalmol.2011.2749.
JAMA Ophthalmology | 
Epidemiology |  June 01, 2012
Attitudes of Physicians, Patients, and Village Health Workers Toward Glaucoma and Diabetic Retinopathy in Rural China:  A Focus Group Study
Xixi Yan, MD; Tianyu Liu, BA; Layla Gruber, BA; et al.
Arch Ophthalmol. 2012;130(6):761-770. doi:10.1001/archophthalmol.2012.145.
JAMA Ophthalmology | 
Editorial |  June 01, 2012
Predicting Risk of Diabetic Retinopathy From Retinal Vessel Analysis:  Personalized Medicine in Transition
Ning Cheung, MD; Tien Yin Wong, MD, PhD
Arch Ophthalmol. 2012;130(6):783-784. doi:10.1001/archophthalmol.2012.727.
JAMA Ophthalmology | 
Epidemiology |  June 01, 2012
Changes in Retinal Vessel Diameter and Incidence and Progression of Diabetic Retinopathy
Ronald Klein, MD, MPH; Chelsea E. Myers, MStat; Kristine E. Lee, MS; et al.
Arch Ophthalmol. 2012;130(6):749-755. doi:10.1001/archophthalmol.2011.2560.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Small Case Series  |  May 2, 2013
Intravitreal Fasudil Combined With Bevacizumab for Persistent Diabetic Macular Edema: A Novel Treatment
Hamid Ahmadieh, MD; Ramin Nourinia, MD; Ali Hafezi-Moghadam, MD, PhD
JAMA Ophthalmology
Clinical Sciences  |  April 18, 2013
Macular Edema After Cataract Surgery in Eyes Without Preoperative Central-Involved Diabetic Macular Edema
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmology
Clinical Trials  |  Mar 2013
Randomized Clinical Trial Evaluating Intravitreal Ranibizumab or Saline for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmology
Clinical Sciences  |  Mar 2013
Automated Analysis of Retinal Images for Detection of Referable Diabetic Retinopathy
Michael D. Abràmoff, MD, PhD; James C. Folk, MD; Dennis P. Han, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems